Bioventix Investor Relations Material

Bioventix PLC is a biotechnology company specializing in the development and supply of high-affinity monoclonal antibodies. These antibodies are used in blood testing and clinical diagnostics for applications such as hormone detection, drug testing, and disease diagnosis. The company focuses on developing antibodies for use in immunoassays, which are employed by global diagnostic companies in laboratory and point-of-care settings. The company is headquartered in Southampton, United Kingdom, and its shares are listed on the London Stock Exchange.